UC San Diego Study Shows DNA Treatment Could Delay Paralysis

In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer’s disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus of the cell. In turn, th

Related Keywords

Jerusalem ,Israel General ,Israel ,Massachusetts ,United States ,Harvard University ,Massachusetts Institute Of Technology ,C Frank Bennett ,Mariana Bravo Hern ,Melindas Beccari ,Clotilde Lagier Tourenne ,Paayman Jafar Nejad ,Vanessa Taupin ,Michaelw Baughn ,Seanm Healey ,Aamir Zuberi ,Roy Maimon ,Stephen Moore ,Maximilliano Presa ,Cathleen Lutz ,Jonathanw Artates ,Sonia Vazquez Sanchez ,Frank Rigo ,Don Cleveland ,Almeida Quadros ,L Sandra Ndayambaje ,Zeev Melamed ,Elena Gonzalo Gil ,Ruth Kirschstein Institutional National Research Service Award ,National Institutes Of Health ,Harvard Medical School ,Brightfocus Foundation ,Jackson Laboratory ,Cancer Center Support Grant ,Packard Center ,Massachusetts Center ,Ionis Pharmaceuticals ,Broad Institute Of Harvard University ,Mouse Resource Research Center ,Hebrew University Of Jerusalem ,Ludwig Institute For Cancer San Diego ,Distinguished Professor ,Molecular Medicine ,California San Diego School ,Eitan Acks ,Ludwig Institute ,Ze Ev Melamed ,Hebrew University ,Karen Ling ,Som Chaturvedi ,Broad Institute ,Massachusetts Institute ,National Institutes ,Alzheimer Therapeutic Science ,Mass General ,